Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT vs VENUS REMEDIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT VENUS REMEDIES WOCKHARDT/
VENUS REMEDIES
 
P/E (TTM) x -15.8 15.1 - View Chart
P/BV x 2.5 1.0 264.6% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 WOCKHARDT   VENUS REMEDIES
EQUITY SHARE DATA
    WOCKHARDT
Mar-23
VENUS REMEDIES
Mar-23
WOCKHARDT/
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs316379 83.3%   
Low Rs145145 100.2%   
Sales per share (Unadj.) Rs184.0415.5 44.3%  
Earnings per share (Unadj.) Rs-43.119.9 -216.9%  
Cash flow per share (Unadj.) Rs-25.744.0 -58.3%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs231.7344.3 67.3%  
Shares outstanding (eoy) m144.0913.37 1,077.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.30.6 198.7%   
Avg P/E ratio x-5.313.2 -40.6%  
P/CF ratio (eoy) x-9.05.9 -150.9%  
Price / Book Value ratio x1.00.8 130.8%  
Dividend payout %00-   
Avg Mkt Cap Rs m33,2023,501 948.2%   
No. of employees `000NANA-   
Total wages/salary Rs m6,370570 1,116.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m26,5105,555 477.2%  
Other income Rs m1,220103 1,181.9%   
Total revenues Rs m27,7305,658 490.1%   
Gross profit Rs m-1,930602 -320.6%  
Depreciation Rs m2,510323 777.1%   
Interest Rs m3,0203 102,721.1%   
Profit before tax Rs m-6,240379 -1,645.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-30114 -26.4%   
Profit after tax Rs m-6,210266 -2,337.6%  
Gross profit margin %-7.310.8 -67.2%  
Effective tax rate %0.530.0 1.6%   
Net profit margin %-23.44.8 -489.8%  
BALANCE SHEET DATA
Current assets Rs m19,1403,230 592.7%   
Current liabilities Rs m34,350826 4,160.1%   
Net working cap to sales %-57.443.3 -132.6%  
Current ratio x0.63.9 14.2%  
Inventory Days Days3937 106.6%  
Debtors Days Days11504 2.2%  
Net fixed assets Rs m48,6702,781 1,749.9%   
Share capital Rs m720134 538.6%   
"Free" reserves Rs m32,6604,470 730.7%   
Net worth Rs m33,3804,603 725.1%   
Long term debt Rs m2,240387 579.1%   
Total assets Rs m70,7506,011 1,177.0%  
Interest coverage x-1.1130.0 -0.8%   
Debt to equity ratio x0.10.1 79.9%  
Sales to assets ratio x0.40.9 40.5%   
Return on assets %-4.54.5 -100.9%  
Return on equity %-18.65.8 -322.4%  
Return on capital %-9.07.7 -118.0%  
Exports to sales %00-   
Imports to sales %3.50-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m920NA-   
Fx inflow Rs m7300-   
Fx outflow Rs m9200-   
Net fx Rs m-1900-   
CASH FLOW
From Operations Rs m1,530366 417.7%  
From Investments Rs m-1,250-508 245.9%  
From Financial Activity Rs m-3,150-6 55,457.7%  
Net Cashflow Rs m-2,800-220 1,270.2%  

Share Holding

Indian Promoters % 54.9 41.8 131.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.5 1.6 281.8%  
FIIs % 4.2 1.6 262.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 45.1 58.2 77.4%  
Shareholders   161,813 19,560 827.3%  
Pledged promoter(s) holding % 74.5 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Wockhardt vs VENUS REMEDIES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Wockhardt vs VENUS REMEDIES Share Price Performance

Period Wockhardt VENUS REMEDIES S&P BSE HEALTHCARE
1-Day 4.99% 7.56% 1.18%
1-Month 0.15% -3.64% -0.75%
1-Year 290.07% 104.08% 61.82%
3-Year CAGR 13.79% 4.79% 18.16%
5-Year CAGR 7.92% 58.20% 19.79%

* Compound Annual Growth Rate

Here are more details on the Wockhardt share price and the VENUS REMEDIES share price.

Moving on to shareholding structures...

The promoters of Wockhardt hold a 54.9% stake in the company. In case of VENUS REMEDIES the stake stands at 41.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Wockhardt and the shareholding pattern of VENUS REMEDIES.

Finally, a word on dividends...

In the most recent financial year, Wockhardt paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

VENUS REMEDIES paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Wockhardt, and the dividend history of VENUS REMEDIES.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.